Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Deracyn: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Deracyn - General Information

Deracyn (Deracyn®) is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Deracyn was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed.

 

Pharmacology of Deracyn

Deracyn is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Deracyn binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.

 

Deracyn for patients

 

Deracyn Interactions

Co-administration with antifungal agents such as ketoconazole or itraconazole is not recommended. Nafazodone, fluvoxamine, cimetidine (consider Xanax dose reduction). Fluoxetine, OCs, sertraline, diltiazem, macrolide antibiotics (exercise caution).

 

Deracyn Contraindications

Hypersensitivity to adinazolam or other benzodiazepines. Adinazolam is also contraindicated in pregnancy, in infants and in patients with myasthenia gravis and acute narrow angle glaucoma.

 

Additional information about Deracyn

Deracyn Indication: For the treatment of anxiety and status epilepticus. Mechanism Of Action: Deracyn binds to peripheral-type benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways. Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Adinazolam Synonyms: Adinazolamum [Inn-Latin] Drug Category: Anti-anxiety Agents; Antidepressive Agents Drug Type: Small Molecule; Approved Other Brand Names containing Adinazolam: Deracyn; Absorption: Not Available Toxicity (Overdose): Signs of overdose may include muscle weakness, ataxia, dysarthria and particularly in children paradoxical excitement. In more severe cases diminished reflexes, confusion, and coma may ensue. Protein Binding: Not Available Biotransformation: Hepatic. The main metabolite is N-desmethyladinazolam. The other two metabolites are alpha-hydroxyalprazolam and estazolam. Half Life: Less than 3 hours. Dosage Forms of Deracyn: Not Available Chemical IUPAC Name: 1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine Chemical Formula: C19H18ClN5 Adinazolam on Wikipedia: https://en.wikipedia.org/wiki/Adinazolam Organisms Affected: Humans and other mammals